Eastern Health Integrated Renal Service

Box Hill 3128

0 studies enrolling now · 2 studies all time

What they study most

End-stage Renal Disease, Hemodiafiltration, Hemodialysis, Lymphoma, Non-Hodgkin, Prevention of Thromboembolic Events

Studies at this site

• Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL) — Stopped early
• Study to Investigate the Safety of a Drug Called Osocimab at Low and High Doses in Adult Patients With Kidney Failure Requiring Regular Hemodialysis — Completed